Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
iShares Treasury Floating Rate Bond ETF
TFLO
$6.72B
| $5.05M | ﹤0.01% |
100,200
+35,869
| +56% | +$1.81M |
|
3677
PUT
StoneCo
STNE
$2.32B
| $5.05M | ﹤0.01% |
655,600
-90,700
| -12% | -$868K |
|
3678
CALL
iShares MSCI Mexico ETF
EWW
$1.86B
| $5.05M | ﹤0.01% |
108,300
-20,800
| -16% | -$1.04M |
|
3679
PUT
iShares MSCI Canada ETF
EWC
$6.56B
| $5.04M | ﹤0.01% |
149,700
+14,800
| +11% | +$548K |
|
|
LPRO
3680
DELISTED
Open Lending Corp
LPRO
| $5.04M | ﹤0.01% |
492,727
+193,139
| +64% | +$2.59M |
|
|
SCUA
3681
DELISTED
Sculptor Acquisition Corp I
SCUA
| $5.04M | ﹤0.01% |
508,223
+1,103
| +0.2% | +$10.9K |
|
|
AMED
3682
CALL
DELISTED
Amedisys
AMED
| $5.04M | ﹤0.01% |
47,900
-11,000
| -19% | -$1.41M |
|
3683
FuelCell Energy
FCEL
$1.79B
| $5.03M | ﹤0.01% |
44,728
-85,165
| -66% | -$10.7M |
|
3684
PUT
PTC Therapeutics
PTCT
$5.98B
| $5.03M | ﹤0.01% |
+125,600
| New | +$4.4M |
|
|
3685
PUT
ResMed
RMD
$32.4B
| $5.03M | ﹤0.01% |
24,000
-9,200
| -28% | -$1.96M |
|
|
UHG
3686
DELISTED
United Homes Group
UHG
| $5.03M | ﹤0.01% |
511,583
-299,978
| -37% | -$2.94M |
|
|
HBI
3687
CALL
DELISTED
Hanesbrands
HBI
| $5.03M | ﹤0.01% |
488,400
-133,400
| -21% | -$1.66M |
|
3688
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$773M
| $5.02M | ﹤0.01% |
104,255
+12,207
| +13% | +$642K |
|
|
GSWO
3689
Goldman Sachs ActiveBeta World Equity ETF
GSWO
$1.81B
| $5.02M | ﹤0.01% |
+134,597
| New | +$5.35M |
|
3690
CALL
iShares Gold Trust
IAU
$64.9B
| $5.01M | ﹤0.01% |
146,100
-24,300
| -14% | -$864K |
|
3691
CALL
Sprouts Farmers Market
SFM
$7.69B
| $5.01M | ﹤0.01% |
198,000
+63,300
| +47% | +$1.76M |
|
3692
PUT
Huntington Ingalls Industries
HII
$12.9B
| $5.01M | ﹤0.01% |
23,000
-21,000
| -48% | -$4.44M |
|
3693
CALL
Jabil
JBL
$38B
| $5.01M | ﹤0.01% |
97,800
+42,200
| +76% | +$2.44M |
|
|
MDH
3694
DELISTED
MDH Acquisition Corp.
MDH
| $5M | ﹤0.01% |
509,085
-1,249,718
| -71% | -$12.3M |
|
3695
J&J Snack Foods
JJSF
$1.67B
| $5M | ﹤0.01% |
35,816
+33,482
| +1,435% | +$4.59M |
|
3696
CALL
Allegiant Air
ALGT
$2.34B
| $5M | ﹤0.01% |
44,200
+18,900
| +75% | +$2.72M |
|
3697
PUT
Lear
LEA
$8.32B
| $5M | ﹤0.01% |
39,700
-10,200
| -20% | -$1.35M |
|
|
IIII
3698
DELISTED
INSU Acquisition Corp. III Class A Common Stock
IIII
| $5M | ﹤0.01% |
507,334
-499,996
| -50% | -$4.92M |
|
|
ALLK
3699
DELISTED
Allakos
ALLK
| $5M | ﹤0.01% |
1,595,753
+221,982
| +16% | +$829K |
|
3700
iShares Core MSCI International Developed Markets ETF
IDEV
$32.7B
| $4.99M | ﹤0.01% |
92,938
-286,815
| -76% | -$16.9M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.